InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Halstead Michael, Vice-Président Exécutif. Director active across 1 company, notably Intra-Cellular Therapies, Inc.. Cumulatively, 6 filings have been published. History available since 21 December 2021. The latest transaction was filed on 21 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
7,906 sharesCommon StockSEC:0001209191-22-013356:0
11,139 sharesCommon StockSEC:0001209191-22-012392:0
19,639 sharesCommon StockSEC:0001209191-22-002989
19,639 sharesCommon StockSEC:0001209191-22-002989:0
25,000 shares@ US$13.86100.0% of flowCommon StockSEC:0001209191-21-071176
25,000 shares@ US$13.8650.0% of flowCommon StockSEC:0001209191-21-071176:0
6 of 6 declarations
About Halstead Michael
Michael Halstead is Executive Vice President and General Counsel at Intra-Cellular Therapies, Inc. He is responsible for the company's legal affairs and compliance. His role is essential in navigating the complex regulatory landscape of the biopharmaceutical sector.
